CrossRef Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease Jimmy Che-To Lai, Boyu Yang, Hye Won Lee, Huapeng Lin, Emmanuel A Tsochatzis, Salvatore Petta, Elisabetta Bugianesi, Masato Yoneda, Ming-Hua Zheng, Hannes Hagstrm, Jerome Boursier, Jose Luis Calleja, George Boon-Bee Goh, Wah-Kheong Chan, Roco Gallego-Du Gut .2025
PMID: 31497854
The focus on sustainable approaches for health is so important
Are Semaglutide and Tirzepatide results the same
Follow-up and adjustment of the plan maintain gains
Nausea can be a sign that the GLP-1 is impacting your gut hormones and digestion speed, but the best way to tell if your medicine is really working is to consider the following questions: Am I feeling less hungry